๐Ÿ•ต๏ธ Gentex Corp ($GNTX)

SEC insider & ownership activity, last 12 months ยท CIK 355811 ยท every row links its SEC filing

Over the last 12 months insiders sold $2.8M with no open-market buying against it. Steven Ray Downing sold $866K in discretionary trades (Feb). No red-flag 8-Ks in the window.

Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Feb 2026: net -$2.2M Mar 2026: net +$0 Apr 2026: net -$112K May 2026: net -$519K Jun 2026: net +$0 Jul 2026: net +$0 Aug 2026: net +$0 Sep 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 9 sellers, $2.8M (13 lots)

InsiderBuysBoughtSellsSoldLast
Steven Ray Downing0โ€“ 1$866KFeb 17, 2026
Matthew William Chiodo0โ€“ 2$496KFeb 17, 2026
Kevin C. Nash0โ€“ 2$297KFeb 17, 2026
Neil J. Boehm0โ€“ 2$279KFeb 17, 2026
Leslie Brown0โ€“ 1$246KMay 5, 2026
Scott Ryan0โ€“ 2$223KFeb 17, 2026
Brian C. Walker0โ€“ 1$136KMay 15, 2026
Joseph B. Anderson Jr.0โ€“ 1$136KMay 15, 2026
Richard Schaum0โ€“ 1$112KApr 30, 2026

5%+ holders

HolderStakeClassScheduleEvent
Vanguard Capital Management 5.3% 13GApr 29, 2026 filing โ†—
Wellington Management Company LLP 5.2% 13GAug 12, 2025 filing โ†—
American Century Investment Management, Inc. 5.2% 13GAug 14, 2026 filing โ†—
American Century Companies, Inc. 5.2% 13GAug 14, 2026 filing โ†—
Stowers Institute for Medical Research 5.2% 13GAug 14, 2026 filing โ†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Leslie Brown$246KMay 5, 2026 filing โ†—
Richard Schaum$112KApr 30, 2026 filing โ†—
Kevin C. Nash$297KFeb 17, 2026 filing โ†—
Steven Ray Downing$866KFeb 17, 2026 filing โ†—
Matthew William Chiodo$496KFeb 17, 2026 filing โ†—
Scott Ryan$223KFeb 17, 2026 filing โ†—
Neil J. Boehm$279KFeb 17, 2026 filing โ†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Jul 24, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 24, 2026 filing โ†—
Shareholder vote (5.07)May 21, 2026 filing โ†—
Earnings (2.02)Apr 24, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 24, 2026 filing โ†—
Earnings (2.02)Jan 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 30, 2026 filing โ†—
Earnings (2.02)Oct 24, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 24, 2025 filing โ†—